These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1313 related articles for article (PubMed ID: 32448269)

  • 41. MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.
    Zheng M; Wu Z; Wu A; Huang Z; He N; Xie X
    Tumour Biol; 2016 Jul; 37(7):8599-607. PubMed ID: 26733177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
    Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
    Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TIPIN depletion leads to apoptosis in breast cancer cells.
    Baldeyron C; Brisson A; Tesson B; Némati F; Koundrioukoff S; Saliba E; De Koning L; Martel E; Ye M; Rigaill G; Meseure D; Nicolas A; Gentien D; Decaudin D; Debatisse M; Depil S; Cruzalegui F; Pierré A; Roman-Roman S; Tucker GC; Dubois T
    Mol Oncol; 2015 Oct; 9(8):1580-98. PubMed ID: 26004086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer.
    Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S
    Cell Signal; 2024 Aug; 120():111196. PubMed ID: 38697448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
    Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y
    EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
    Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S
    Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SALL4 promotes tumor progression in breast cancer by targeting EMT.
    Chen T; Tsang JYS; Su XC; Li P; Sun WQ; Wong ILK; Choy KY; Yang Q; Tse GMK; Chan TH; Chow LMC
    Mol Carcinog; 2020 Oct; 59(10):1209-1226. PubMed ID: 32835442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.
    Bhardwaj A; Singh H; Rajapakshe K; Tachibana K; Ganesan N; Pan Y; Gunaratne PH; Coarfa C; Bedrosian I
    Oncotarget; 2017 Mar; 8(12):19645-19660. PubMed ID: 28160548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
    Li B; Huang L; Ruan J
    Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells.
    Wo L; Lu D; Gu X
    Tumour Biol; 2016 Oct; 37(10):13733-13742. PubMed ID: 27476169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Tang H; Chen B; Liu P; Xie X; He R; Zhang L; Huang X; Xiao X; Xie X
    Carcinogenesis; 2019 Oct; 40(10):1278-1287. PubMed ID: 30810729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion.
    Zhang Y; Liu F; Zhang C; Ren M; Kuang M; Xiao T; Di X; Feng L; Fu L; Cheng S
    Am J Pathol; 2020 Jan; 190(1):37-47. PubMed ID: 31610177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor.
    Kim HY; Ha Thi HT; Hong S
    Cancer Lett; 2018 Feb; 415():30-39. PubMed ID: 29217458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TFAP2A downregulation mediates tumor-suppressive effect of miR-8072 in triple-negative breast cancer via inhibiting SNAI1 transcription.
    Fang Y; Wang Y; Ma H; Guo Y; Xu R; Chen X; Chen X; Lv Y; Li P; Gao Y
    Breast Cancer Res; 2024 Jun; 26(1):103. PubMed ID: 38890750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.